Skip to main content
20 minutes minimum delay
toggle main navigation
Our Approach
Our Approach
NDMA Receptors
Therapeutic Area Focus
Pipeline
Clinical Studies
Investors
About Us
About Aptinyx
Leadership Team
Board of Directors
Working at Aptinyx
Contact Us
Site Search
SEC Filings Details
Investor Relations
Press Releases
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
Analyst Coverage
Financials & Filings
Quarterly Results
Annual Reports & Proxy
SEC Filings
Governance
Governance Documents & Charters
Executive Management
Board of Directors
Committee Composition
FAQ & Contacts
Investor Contacts
Investor FAQs
Investor Email Alerts
RSS Feeds
Form
8-K
December 01, 2022
Current report filing
PDF Format Download (opens in new window)
Word Format Download (opens in new window)
Excel Format Download (opens in new window)
XBRL Format Download (opens in new window)
XBRL Format Download (opens in new window)